Research Article

Association of Symptoms of Gastroesophageal Reflux with Metabolic Syndrome Parameters in Patients with Endocrine Disease

Table 5

Clinical parameters and GERD risk.

Number of subjects (%)OR (95% CI)*
FSSG ≤ 7FSSG ≥ 8

BMI ≥ 25 kg/m226/93 (28.0)7/18 (38.9)1.54 (0.52–4.57)
Waist circumference35/93 (37.6)5/18 (27.8)0.74 (0.22–2.50)
SBP ≥ 140 mmHg13/92 (14.1)2/18 (11.1)0.75 (0.14–3.97)
DBP ≥ 90 mmHg3/92 (3.3)1/18 (5.6)1.27 (0.10–16.05)
FBS ≥ 110 mg/dL18/63 (28.6)2/12 (16.7)0.49 (0.09–2.63)
Triglyceride ≥ 150 mg/dL14/63 (22.2)6/12 (50.0)5.85 (1.17–29.25)
TC ≥ 220 mg/dL23/63 (36.5)2/12 (16.7)0.33 (0.06–1.76)
HDL-C < 40 mg/dL1/57 (1.8)2/9 (22.2)23.06 (0.88–605.63)
Uric Acid ≥ 7.0 mg/dL8/63 (12.7)1/12 (8.3)0.79 (0.08–8.09)
Cortisol ≥ 9.5  g/dL12/23 (52.2)3/8 (37.5)0.08 (0.004–1.87)
Free T4 ≥ 1.27 ng/mL20/40 (50.0)4/8 (50.0)1.09 (0.20–5.87)
TSH ≥ 1.28 ng/mL20/40 (50.0)4/8 (50.0)1.04 (0.20–5.42)

Sex, age, BMI, and diagnoses of subjects adjusted odds ratio.
≥85 cm (male), ≥90 cm (female).